HF
CDIO icon

HRT Financial’s Cardio Diagnostics CDIO Stock Holding History

HRT Financial’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$121K Buy
+62,482
New +$163K ﹤0.01% 3313
2025
Q2 		– Sell
-1,488
Closed -$14K – 2707
2025
Q1 		$14K Sell
1,488
-3,692
-71% -$57.5K ﹤0.01% 2327
2024
Q4 		$142K Buy
5,180
+4,813
+1,311% +$66.7K ﹤0.01% 1999
2024
Q3 		$2K Buy
+367
New +$4.5K ﹤0.01% 2295
2023
Q4 		– Sell
-376
Closed -$3K – 2379
2023
Q3 		$3K Buy
+376
New +$9.04K ﹤0.01% 2216

Other funds holding CDIO

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

HRT Financial's CDIO Position: Q1 2026 in Review

HRT Financial opened a new position in Cardio Diagnostics (CDIO) in Q1 2026: 62,482 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #3313 among its holdings. This is a return to the name: HRT Financial previously reported a position in CDIO as recently as Q1 2025.

HRT Financial first reported a position in CDIO in Q3 2023 and has held it in 5 quarters since. The position peaked at $142K in Q4 2024. 16 funds tracked by Wall St. Rank hold CDIO as of Q1 2026.

  • HRT Financial held 62,482 shares of Cardio Diagnostics worth $121K as of Q1 2026.
  • Cardio Diagnostics was a new HRT Financial position in Q1 2026.
  • Cardio Diagnostics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3313 holding.
  • HRT Financial first reported a position in Cardio Diagnostics in Q3 2023 and has held it in 5 quarters since.
  • HRT Financial's Cardio Diagnostics position peaked at $142K in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.